ProCE Banner Activity

Novel Emerging Investigational Treatment Strategies for Patients With Myelofibrosis

Podcast Episodes

Listen to expert commentary on emerging strategies in clinical trial development for treating patients with myelofibrosis, with a focus on alternatives to JAK inhibitors.

Released: November 30, 2023

Share

Faculty

Jacqueline S. Garcia

Jacqueline S. Garcia, MD

Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts 

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant AbbVie Inc.

AbbVie Inc.

Disclosure

Primary Author

Jacqueline S. Garcia, MD

Assistant Professor of Medicine
Harvard Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts 

Jacqueline S. Garcia, MD: consultant/advisor/speaker: AbbVie, Bristol Myers Squibb, Genentech, Sanofi, Servier.